Sanofi (SNY) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Sanofi Revenue Highlights


Latest Revenue (Y)

$43.07B

Latest Revenue (Q)

$11.12B

Main Geography (Y)

Reportable Geographical Zones

Sanofi Revenue by Period


Sanofi Revenue by Year

DateRevenueChange
2023-12-31$43.07B-5.11%
2022-12-31$45.39B15.86%
2021-12-31$39.17B4.83%
2020-12-31$37.37B-0.70%
2019-12-31$37.63B5.48%
2018-12-31$35.68B-1.50%
2017-12-31$36.22B4.40%
2016-12-31$34.70B-0.47%
2015-12-31$34.86B8.94%
2014-12-31$32.00B2.26%
2013-12-31$31.29B-12.98%
2012-12-31$35.96B2.56%
2011-12-31$35.06B9.44%
2010-12-31$32.03B4.18%
2009-12-31$30.75B6.70%
2008-12-31$28.82B-1.49%
2007-12-31$29.25B-0.80%
2006-12-31$29.49B3.50%
2005-12-31$28.49B89.54%
2004-12-31$15.03B87.10%
2003-12-31$8.03B7.77%
2002-12-31$7.46B14.91%
2001-12-31$6.49B8.80%
2000-12-31$5.96B11.46%
1999-12-31$5.35B-

Sanofi generated $43.07B in revenue during NA 2023, up -5.11% compared to the previous quarter, and up 120.72% compared to the same period a year ago.

Sanofi Revenue by Quarter

DateRevenueChange
2024-03-31$11.12B-51.41%
2023-12-31$22.88B80.21%
2023-09-30$12.70B18.87%
2023-06-30$10.68B-1.67%
2023-03-31$10.86B-5.18%
2022-12-31$11.46B-12.80%
2022-09-30$13.14B22.30%
2022-06-30$10.74B6.85%
2022-03-31$10.05B-3.48%
2021-12-31$10.41B-3.82%
2021-09-30$10.83B19.72%
2021-06-30$9.04B1.79%
2021-03-31$8.89B-8.73%
2020-12-31$9.74B-1.45%
2020-09-30$9.88B17.08%
2020-06-30$8.44B-9.42%
2020-03-31$9.32B-7.00%
2019-12-31$10.02B0.97%
2019-09-30$9.92B10.48%
2019-06-30$8.98B3.06%
2019-03-31$8.71B-6.57%
2018-12-31$9.33B-4.29%
2018-09-30$9.74B14.89%
2018-06-30$8.48B4.37%
2018-03-31$8.13B-9.69%
2017-12-31$9.00B-4.21%
2017-09-30$9.39B5.00%
2017-06-30$8.95B0.55%
2017-03-31$8.90B-3.05%
2016-12-31$9.18B-1.27%
2016-09-30$9.29B11.88%
2016-06-30$8.31B4.79%
2016-03-31$7.93B16.08%
2015-12-31$6.83B-29.44%
2015-09-30$9.68B2.31%
2015-06-30$9.46B6.42%
2015-03-31$8.89B-3.05%
2014-12-31$9.17B3.41%
2014-09-30$8.87B8.86%
2014-06-30$8.15B2.79%
2014-03-31$7.92B-7.26%
2013-12-31$8.54B0.32%
2013-09-30$8.52B5.34%
2013-06-30$8.09B-0.87%
2013-03-31$8.16B-5.84%
2012-12-31$8.66B-6.24%
2012-09-30$9.24B1.35%
2012-06-30$9.12B2.01%
2012-03-31$8.94B0.16%
2011-12-31$8.92B-2.71%
2011-09-30$9.17B4.57%
2011-06-30$8.77B7.07%
2011-03-31$8.19B4.89%
2010-12-31$7.81B-5.44%
2010-09-30$8.26B0.83%
2010-06-30$8.19B5.35%
2010-03-31$7.78B0.60%
2009-12-31$7.73B-0.55%
2009-09-30$7.77B-0.32%
2009-06-30$7.80B4.64%
2009-03-31$7.45B-0.07%
2008-12-31$7.46B4.06%
2008-09-30$7.17B0.85%
2008-06-30$7.10B0.14%
2008-03-31$7.09B-13.10%
2007-12-31$8.16B-

Sanofi generated $11.12B in revenue during Q1 2024, up -51.41% compared to the previous quarter, and up 97.05% compared to the same period a year ago.

Sanofi Revenue Breakdown


Sanofi Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
North America$19.22B$18.98B$15.07B--
FRANCE$2.38B$2.30B$2.26B$2.22B$2.26B
Europe$10.39B$10.00B---
Reportable Geographical Zones$43.07B$43.00B$37.76B$36.04B-
Other Countries-$14.01B$12.93B$12.83B$13.90B
Europe 1---$9.15B$8.85B
North America 1---$14.06B$13.37B
Reportable geographical zones----$36.13B

Sanofi's latest annual revenue breakdown by geography, as of Dec 23: Reportable Geographical Zones (57.38%), North America (25.60%), Europe (13.85%), and FRANCE (3.17%).

Quarterly Revenue by Country

CountryDec 23Jun 23Jun 22
North America$10.95B$8.26B$7.88B
FRANCE$1.21B$1.17B$1.10B
Reportable Geographical Zones$22.88B$20.19B$19.79B

Sanofi's latest quarterly revenue breakdown by geography, as of Dec 23: Reportable Geographical Zones (65.31%), North America (31.26%), and FRANCE (3.44%).

Sanofi Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
JNJJohnson & Johnson$85.15B$22.47B
MRKMerck$60.12B$16.11B
ABBVAbbVie$54.32B$14.46B
NVSNovartis$46.66B$11.83B
AZNAstraZeneca$45.81B$12.68B
BMYBristol-Myers Squibb Company$45.01B$11.89B
SNYSanofi$43.07B$11.12B
GSKGSK$30.33B$7.36B
AMGNAmgen$28.19B$8.50B
GILDGilead Sciences$27.12B$6.95B

SNY Revenue FAQ


Sanofi's yearly revenue for 2023 was $43.07B, representing a decrease of -5.11% compared to 2022. The company's yearly revenue for 2022 was $45.39B, representing an increase of 15.86% compared to 2021. SNY's yearly revenue for 2021 was $39.18B, representing an increase of 4.83% compared to 2020.

Sanofi's quarterly revenue for Q1 2024 was $11.12B, a -51.41% decrease from the previous quarter (Q4 2023), and a 2.35% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $22.88B, a 80.21% increase from the previous quarter (Q3 2023), and a 99.75% increase year-over-year (Q4 2022). SNY's quarterly revenue for Q3 2023 was $12.7B, a 18.87% increase from the previous quarter (Q2 2023), and a -3.35% decrease year-over-year (Q3 2022).

Sanofi's revenue growth rate for the last 3 years (2021-2023) was 9.94%, and for the last 5 years (2019-2023) was 14.45%.